NCT05078983

Brief Summary

Frailty is a term specific to the geriatric period. It is used to describe weak, unstable, frail patients and partially expresses the frailty of the elderly patient. Once the frailty process begins, the risk of loss of mobility, dependency and mortality increases. Frailty is an important predictor of adverse outcomes after surgery. According to studies conducted in various surgical situations, fragility is a major risk factor for morbidity, mortality and longer hospital stay. According to the available data, frailty has a sufficient basis for determining the risks of patients before surgery, developing preventive methods and making personal treatment decisions. As the frailty index increased, it was observed that the duration of postoperative hospital stay was associated with the need for intensive care, postoperative complications, and the rate of re-admissions within 30 days. ASA (American Society of Anesthesiologists) classification is widely used in order to evaluate the physical condition preoperatively in geriatric individuals with multiple comorbidities. Considering the fragility variable while creating the ASA score in the preoperative period may be useful in determining the follow-up strategy during the operation and postoperative period. For example, a patient who is evaluated as ASA 2 because he has no problems other than simple 1-2 comorbid conditions, involuntary weakening of 5% in the last 1 year (not easily noticed), weakness (can only be detected with a dynamometer) and cessation of going out of the house (can only be understood when asked privately). ) can be categorized as at risk at ASA level 3-4, as it is understood to be fragile. The aim of this project is to examine the frequency of frailty in elderly individuals who will be operated on, and to examine the relationship between frailty and ASA score using the anthropometry and comorbidity differences between frail preoperative patients and those who do not.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 17, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 22, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

October 15, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 17, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 17, 2022

Completed
Last Updated

August 4, 2022

Status Verified

August 1, 2022

Enrollment Period

1.2 years

First QC Date

September 22, 2021

Last Update Submit

August 3, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • DEATH RATE

    PROPORTION OF PATIENTS WHO DIED TO ALL PATIENTS

    AT 1 MONTH AND 3 MONTH AFTER OPERATION

  • LENGTH OF HOSPITAL STAY

    NUMBER OF NIGHTS THE PATIENT NEEDS TO STAY IN HOSPITAL

    AT 1 MONTH

  • DELIRIUM RATE

    THE RATIO OF THE NUMBER OF PATIENTS IN DELIRIUM TO THE TOTAL NUMBER OF PATIENTS AFTER OPERATION

    AT 1 MONTH

  • INTENSIVE CARE RATE

    THE RATIO OF THE NUMBER OF PATIENTS NEED INTENSIVE CARE AFTER OPERATION TO TOTAL NUMBER OF PATIENTS

    AT 1 MONTH

Study Arms (2)

HIGH RISK

HIGH RISK MEANS PATIENTS HAVE ASA SCORE OVER 2

Diagnostic Test: CGA-FI (COMPREHENSIVE GERIATRIC ASSESMENT - FRAILITY INDEX)

LOW RISK

LOW RISK MEANS PATIENTS HAVE ASA SCORE BELOW 3

Diagnostic Test: CGA-FI (COMPREHENSIVE GERIATRIC ASSESMENT - FRAILITY INDEX)

Interventions

GERIATRIC ASSESMENT TEST

HIGH RISKLOW RISK

Eligibility Criteria

Age65 Years+
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients over the age of 65 who were admitted to the general surgery service for surgery and then operated.

You may qualify if:

  • \- Patients over the age of 65 who were admitted to the general surgery service for surgery and then operated.

You may not qualify if:

  • Patients with advanced stage dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulhane training and research hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Muscle Weakness

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 22, 2021

First Posted

October 15, 2021

Study Start

August 17, 2021

Primary Completion

October 17, 2022

Study Completion

November 17, 2022

Last Updated

August 4, 2022

Record last verified: 2022-08

Locations